Oxford University’s RECOVERY clinical trial has found that low-dose dexamethasone increases the chance of survival in patients with COVID-19 who require respiratory support. In the study, the drug ...

The Food and Drug Administration has given ANI its approval for generic dexamethasone tablets in dosage strengths of 1.5 mg, 4 mg and 6 mg. The company’s dexamethasone tablets are the generic of ...

Incidence of infections in clinical trials of treatments for relapsed/refractory multiple myeloma: Systematic review and meta-analysis. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...

Dexamethasone became the latest drug to get attention for its potential in treating COVID, when a study declared this week there were promising results in trials with the drug. But what exactly is ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it is launching dexamethasone, 4mg and 6 mg, following Abbreviated New ...

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) said on Tuesday that it has received approval from the FDA for the Abbreviated New Drug Application for Dexamethasone Tablets USP 1.5mg, 4mg, and 6mg.

Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A cheap, widely available steroid called dexamethasone reduced deaths by up to one third in severely ...

LONDON — An inexpensive steroid reduced deaths from coronavirus infection, helping some of the sickest patients with severe lung damage survive the illness, according to British clinical trial results ...

Dexamethasone became the latest drug to get attention for its potential in treating COVID, when a study declared this week there were promising results in trials with the drug. But what exactly is ...